Vol. 67, No. 2, 1975
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
STIMULATION OF TRIGLYCERIDESYNTHESIS IN MAMMALIANLIVER AND ADIPOSE TISSUE BY TWOCYTOSOLICCOMPOUNDS* Daniel Institute
A.K.
Roncari+
of Medical Department
Science
September
Y.W. Mack
and Toronto
of Medicine, Toronto,
Received
and Esther
Western
University
Hospital,
of Toronto,
Canada M5S lA8
22,1975
SUMMARY Two cytosolic compounds which stimulate neutral glyceride synthesis catalyzed by microsomal enzymes have been isolated from both rat liver and adipose tissue. In their absence, diacyl-sn-glycero-3-phosphate was the major product. They were separated from each other by Sephadex G-100 chromatography; in the case of each tissue, one had a molecular weight greater than 150,000, while the other was in the range 8,000-16,000. Both were inactivated by trypsin and the smaller one lost only 25% of its activity after incubation at pH 8.3, 90°, one hour. While Mg2+ also increased neutral glyceride synthesis, the cytosolic factors were active under optimal concentrations of these ions. These compounds may play a critical role in the regulation of neutral glyceride synthesis. The regulation understood. supernatant
of glycerolipid
A stimulatory fraction)
effect
compound(s)
intestine
the
is poorly
cytosol
synthesis
for and is
the
effect
the
subject
(l-3).
tissue, The nature
of the of
(100,000 catalyzed
in mammalian adipose
has been reported
responsible
has been investigated
of
on triglyceride
membranous enzymes present and small
biosynthesis
cytosolic
this
X g by liver of the fraction
report.
*This work was supported by The Medical Research Council of Canada Grant MA-4428, The Ontario Heart Foundation, The Atkinson Charitable Foundation and The Banting Research Foundation. +Scholar of the Medical Research Council of Canada. To whom reprint requests should be addressed at the Medical Sciences Building, Room 7238, University of Toronto, Toronto, Canada M5S lA8. Copyright o I9 75 by Academic Press, Inc. All rights of reproductim in any form reserved.
790
Vol. 67, No. 2, 1975
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
MATERIALS AND METHODS Materials. Palmitic acid, rat-glycerophosphate, ATP (Na salt), CoA (Li salt), horse muscle myoglobin (Type I) (Sigma), lipid standards (Sigma and Serdary Research Laboratories), [U-14C]-snglycero-3-phosphate (120 Ci/mol) (New England Nuclear), Blue Dextran 2,000 and Sephadex G-100 (fine) (Pharmacia) were purchased from the designated sources. Livers and epididymal fat pads were obtained from Methods. At the time fasted-refed (48-48 hours) male albino Wistar rats. Homogenization was carried of sacrifice, they weighed 190-230 g. out at 0-4O in 0.005 M ammonium acetate adjusted to pH 8.3 with the homogenizing solution consisted NH4OH. In some experiments, of 0.01 M potassium phosphate, pH 7.0, 0.15 M KCl, 0.25 M sucrose and 0.01 M 2-mercaptoethanol. Livers were homogenized with a Waring Blendor, while epididymal fat pads were homogenized with a motor-driven Potter-Elvehjem apparatus (Teflon pestle). In the case of each tissue, after initial centrifugation at 15,000 X g for 20 min, the microsome-rich and the cytosolic (supernate) fractions were obtained at 100,000 X g for 60 min (all centrifugations at 0-4O). Incubations were carried out using optimal concentrations of known substrates (sn-glycero-3-phosphate and potassium palmitate) and cosubstrates (ATP and CoA) as previously reported (1) except for the fact that the radioactive substrate was [U-14C]-sn-glycero-3-phosphate (1 uCi per assay), the concentration of potassium phosphate was 0.1 M, 2-mercaptoethanol (0.01 M) was used and, unless otherwise specified, the concentration of MgC12 was 0.2 mM, in a total volume of 0.5 ml. Microsome-rich fractions of epididymal adipose tissue or liver were used in the presence or absence of adipose tissue or liver cytosol or partially purified fractions of the latter. Incubations were conducted at 25" for 15 min. Lipid extraction was carried out by the method of Bligh and Dyer (4) using methanol which contained 0.01 M rac-glycerophosphate and 0.1 N HCl instead of water. The lipids were separated by thin-layer chromatography on Silica Gel H as reported Fifty ug of authentic lipid were used as "carrier" for each (1). glycerolipid formed. After visualization with 12, the Silica containing the various lipid fractions was scraped and the radioactivity counted in a Nuclear-Chicago Mark II liquid scintillation spectrometer model 6847 using Bray's mixture. Protein concentrations were determined by a microbiuret procedure (5). Magnesium concentrations were determined by atomic absorption spectrometry (6). The liver cytosolic factors were resolved by chromatography on 2.5 X 60 cm Sephadex G-100 (fine) columns (Glenco Scientific, Inc.) equilibrated and eluted with 0.005 M ammonium acetate, pH 8.3, at O-4". Appropriate eluate fractions were concentrated by rotary evaporation prior to assay. RESULTS The effect glycerolipids Fig.
1.
some-rich
of
the
formed
Various
cytosolic
by microsomal
combinations
and cytosolic
fraction
of
fractions
on the
enzymes liver
illustrated
or adipose
were used.
791
is
composition
tissue
of in
micro-
Under the experi-
Vol. 67, No. 2, 1975
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
7:
AM AMtLS
Fig. 1. Effects of liver or adipose tissue cytosol on glycerolipid synthesis catalyzed by liver or adipose tissue microsome-rich fractions. In the appropriate incubation mixtures, the following quantities of protein were used: liver cytosol (IS) 5.0 mg, adipose tissue cytosol (AS) 3.0 mg, liver microsome-rich fraction (LM) 0.8 mg and adipose tissue microsome-rich fraction (AM) 1.0 m1,2-diacyl-sn-glycero-3phosphate, m-- diglyceride, - triglyceride.
mental
conditions
catalyzed
used in this
predominantly
phosphate.
the
Diglyceride
products,
while
and adipose 7- and 3-fold
of
liver
microsomal
the
total
radioactive
was negligible.
fraction
resulted
respectively,
enzymes
1,2-diacyl-sn-glycero-3-
4% of
synthesis
cytosolic
increase,
the
synthesis
constituted
triglyceride
tissue
study,
in the
The liver
in an approximately diglyceride
frac-
tion. In the case of the
adipose
diacyl-sn-glycero-3-phosphate formed,
but
products
in appreciable ride
fraction
1).
constituted Both
adipose
enhancement and the
microsome-rich
was also
triglyceride
(Fig.
tissue
about tissue
of both
latter
the major 20% of
and liver
glycerolipid the radioactive cytosol
the diglyceride
became the major
fraction,
resulted
and triglyce-
glycerolipid
form-
ed. The resolution capable
of
enhancing
adipose
tissue
of two factors neutral
microsomal
derived
glyceride
enzymes 792
is
from liver
synthesis illustrated
cytosol
catalyzed in Fig.
and
by 2.
The
Vol. 67, No. 2, 1975
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
P 2
n x ,"
IOO-
g 2 0
80-
.i P E =
60-
40-
z if 8
zo-
0
I 80
40
I 120
I 160
I 200
Elude
I 280
240
I 320
360
(ml)
Fig. 2. Resolution of liver cytosolic factors which stimulate neutral glyceride synthesis by Sephadex G-100 chromaOne ml of concentrated cytosol was applied onto a tography. 2.5 X 60 cm column equilibrated and eluted with 0.005 M ammonium acetate, pH 8.3, at 4O. The fractions of the eluate between the horizontal T symbols were pooled and concentrated. In separate assays, the partially purified factors I and II (20 and 11 mg of total protein, respectively) were tested in the presence of 0.3 mg of adipose tissue microsomal protein. Vo-column exclusion volume, Ve myoglobin-elution volume of myoglobin added as a marker, Vi-internal column volume ("salt fraction"). m1,2-diacyl-snglycero-3-phosphate, m -- diglyceride, 0 - triglyceride.
column eluting the
quantity
obtained Fig.
"salt
volume I;
smaller
it
glyceride
contained enhanced
factor(s)
portion regions
which
proportion
be referred
increment proportion
was reproduced
in the
of
to
the eluate.
will
eluate
as factor
diglyceride (Fig. II)
fraction, The effect (Fig.
repro-
be referred
fraction
of diglyceride.
793
to those
The column exclu-
of both
triglyceride
in 30 experiments
presence,
of the
synthesis.
a factor(s) the
in its were similar
by the microsome-rich (will
on the
(Vi)
two distinct
neutral
formed
an appreciable no effect
(Vo)
composition
fraction"
that
enhanced
triglyceride
factor
the
2 illustrates
as factor
was used as control;
and glycerolipid
with
ducibly sion
solution
2).
to and
2).
A
resulted
in
but
had
of each
Vol. 67, No. 2, 1975
BIOCHEMICAL
No Added
AND BIOPHYSICAL RESEARCH COMMUNiCATlONS
Mg’+
02mM
MgCIz
3mM M&I, I I/
0
Fig. 3. Effects of liver cytosolic factors on glycerolipid synthesis catalyzed by adipose tissue microsome-rich fractions in the presence of different concentrations of added M$+. After resolution by Sephadex G-100 chromatography, the partially purified factors I and II (34 and 15 mg of total protein, respectively) were assayed in the presence of 0.3 mg of adipose tissue microsomal protein. m - 1,2-diacyl-sn-glycero3-phosphate, m - diglyceride, 0 - triglyceride.
The molecular 150,000,
weight
while
that
The effects
of
of
the
of the
larger smaller
compound was greater
than
one was in the
8,000-
range
16,000.
composition some-rich of
ride
cytosolic
of glycerolipids fraction
and triglyceride.
persisted required
in for
the
The total
endogenou;
Sephadex
G-100 eluate
range
0.3-0.4
3.
Three
fraction
were the
for
resulted
relative
formed
factor which
were
when 10 mM
same as those
shown for
either
0.2 mM MgC12, increment
794
diglyce-
synthesis;
associated
factor
When an equimolar
MnC12 was substituted
micro-
mM MgC12 resulted
of newly
magnesium concentration containing
tissue
of each cytosolic
glyceride
results
on the
concentrations
of MgCl2 concentrations
neutral
meq/liter.
in a similar
adipose
of different
The effect
maximal
I and II
by the
in Fig.
in the
the presence
MgC12 was used,
presence
illustrated
in an increase
factors
formed
in the
added MgC12 is
by itself
liver
I or II
concentration
each cytosolic in the neutral
with
3 mM. the
was in the of compound glyce-
BIOCHEMICAL
Vol. 67, No. 2, 1975
ride of
fraction. soybean
enzymes, of the
trypsin
prior
to
and cosubstrates
by trypsin;
incubation
addition
with
prevented
membranous
any further
effect
protease. cytosolic
factor
I was inactivated
M ammonium acetate,
was stable vity
was inactivated
inhibitor
substrates
Liver 0.005
Each factor
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
under
these
when preincubated
pH 8.3,
at 60" for
conditions
and lost
at
1 hour.
90'
by preincubation
for
1 hour: only
in
factor
25% of
II
its
acti-
DISCUSSION The current liver
study
cytosolic
thesis
compounds which
catalyzed
which
similar
or identical
viously
presented
fraction 3.4) as its
reports
3, 8).
heat
an activator larger these
The properties
catalytic
remains
the
tissue
protein
syn-
enzymes.
in nature,
adipocyte
effect
the
of
that
smaller
it
is
not
The precise
to be elucidated.
triglyceride
glyceride
factors
the
are pre-
cytosolic
phosphohydrolase"
activity.
liver
two rat
(7).
of
indicate
of
compound,
such
an enzyme,
but
nature
of the
The relationship
cytosolic synthesis
(EC 3.1.
factor
reported
from diglyceride,
of to be is not
(9). It
for
laboratory
phosphatidate
compounds to the for
partly
two cytosolic
have ascribed
stability, of
factor
required clear
by this
to a "soluble (2,
the
neutral
and adipose
are at least
to
the presence
stimulate
by membranous liver
These compounds,
Earlier
has demonstrated
has been reported
the effect
phosphatidate in addition neutral centrations
of
the
that
in rat
cytosolic
fraction
phosphohydrolase to Mg*+,
glyceride
(10).
two larger
synthesis;
adipose
by activating This
cytosolic
they
of Mg'+.
795
tissue
are active
study
Mg2+ account microsomal
has revealed
that,
compounds stimulate at
saturating
con-
Vol. 67, No. 2, 1975
Hence, ride
two cytosolic
synthesis
tissue.
BIOCHEMICAL
compounds which
have been isolated
They may play
synthetic
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
enhance
from both
a critical
role
neutral
liver
glyce-
and adipose
in regulating
this
bio-
process.
ACKNOWLEDGEMENTS The authors are grateful tance. They are also thankful the magnesium concentrations.
to Mr. Henry Wang for to Dr. H. Husdan for
his assisdetermining
REFERENCES 1.
Roncari, D.A.K., Acta Biophys.
2.
Hiibscher, (1967)
G., Brindley, D.N., Nature G,-449-453.
3.
Johnston, (1967)
J.M., Lipids
4.
Bligh, 37,
5.
Munkres, K.D., and Richards, Biophys. 109, 466-479.
6.
Pybus,
7.
Roncari,
8.
Smith, M.E., Sedgwick, B., Brindley, D.N., (1967) European J. Biochem. 3, 70-77.
9.
Manley, E.R., Skrdlant, H.B., Hansbury, E., and Scallen, (1974) Biochem. Biophys. Res. Commun. 58, 229-235.
10.
Jamdar, 524.
and Hollenberg, 137, 446-463.
Rao, G.A., 2,.14-20;
E.G., and Dyer, 911-917.
J.
(1968) D.A.K.
S.C.,
Clin. (1974)
and Fallon,
C.H. Smith,
Lowe, P.A.,
W.J.
(1967) M.E.,
and Sedqwick,
and Schwarz,
(1959 ) Can. J. F.M.
(1965)
Biochem.
Arch.
Chim. Acta
23,
309-317.
Fed.
33,
1525.
Proc.
H.J.
796
(1973)
Biochim.
J.
B.E. Physio 1.
Biochem.
and Hiibscher,
Lipid
B.
Res. 14,
G. T.J. 517-